Role of platinum-DNA adduct formation and removal in cisplatin resistance in human ovarian cancer cell lines
- 11 February 1994
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 47 (4), 689-697
- https://doi.org/10.1016/0006-2952(94)90132-5
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Mechanisms of drug resistance in ovarian cancerCancer, 2010
- Cellular glutathione (GSH) and glutathione S-transferase (GST) activity in human ovarian tumor biopsies following exposure to alkylating agentsInternational Journal of Radiation Oncology*Biology*Physics, 1992
- Inhibition of transcription and strand-specific DNA repair by α-amanitin in Chinese hamster ovary cellsMutation Research/DNA Repair, 1992
- Transcription-dependent and independent DNA excision repair pathways in human cellsMutation Research/DNA Repair, 1992
- Ovarian cancer, Part I: BiologyCurrent Problems in Cancer, 1992
- Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation.Journal of Clinical Investigation, 1991
- Resistance to alkylating agents and cisplatin: Insights from ovarian carcinoma model systemsPharmacology & Therapeutics, 1990
- Overexpression of Metallothionein Confers Resistance to Anticancer DrugsScience, 1988
- Enhanced DNA repair as a mechanism of resistance to cis-diamminedichloroplatinum(II)Biochemistry, 1988
- Processing of psoralen adducts in an active human gene: Repair and replication of DNA containing monoadducts and interstrand cross-linksCell, 1987